BIOMAT Database Logo BIOMAT Database Logo

Complete response with crizotinib in two children with chemotherapy resistant neuroblastoma. 2017

Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Department of Pediatric Oncology and Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.

UI MeSH Term Description Entries

Related Publications

Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma.
February 2016, Clinical cancer research : an official journal of the American Association for Cancer Research,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Complete surgical resection plus chemotherapy prolongs survival in children with stage 4 neuroblastoma.
February 2005, Pediatric surgery international,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Immunotherapy and chemotherapy in children with neuroblastoma.
September 1976, Journal of the National Cancer Institute,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring ALK Y1278S Mutation.
December 2019, JCO precision oncology,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Intensive chemotherapy in children with stage IV neuroblastoma.
January 1999, Indian journal of pediatrics,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Two-year crizotinib monotherapy induced durable complete response of pediatric ALK-positive inflammatory myofibroblastic tumor.
August 2023, Pediatric blood & cancer,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Extraordinary response to crizotinib in a woman with squamous cell lung cancer after two courses of failed chemotherapy.
May 2014, BMC pulmonary medicine,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Complete Pathological Response to Crizotinib in a Patient with ALK-rearranged Lung Adenocarcinoma.
January 2020, Clinical lung cancer,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Response to chemotherapy, reexposure to crizotinib and treatment with a novel ALK inhibitor in a patient with acquired crizotinib resistance.
January 2014, Respiration; international review of thoracic diseases,
Priyanka Verma, and Sandeep Jain, and Gauri Kapoor
Oral Metronomic Topotecan Sensitizes Crizotinib Antitumor Activity in ALKF1174L Drug-Resistant Neuroblastoma Preclinical Models.
August 2017, Translational oncology,
Copied contents to your clipboard!